Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Recruiting 3 Active not recruiting 3 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Melanoma 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Cancer Recurrent 1 Safety Issues 1 Recurrent Liver Cancer After Liver Transplantation 1 Recurrence 1 Radiation Pneumonitis 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced or Metastatic Solid Tumors 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1

Interventions

Paclitaxel 35 Carboplatin 35 Bevacizumab 14 olaparib 13 niraparib 11 apatinib 11 Gemcitabine 10 liposomal doxorubicin 9 Hyperthermic Intraperitoneal Chemotherapy 9 Cisplatin 9 pembrolizumab 8 Cyclophosphamide 8 fludarabine 7 Etoposide 7 Topotecan 6 fluzoparib 5 Surveys and Questionnaires 5 Drug Therapy 5 Albumin-Bound Paclitaxel 5 anlotinib 4 Immunohistochemistry 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Cytoreduction Surgical Procedures 4 Taxes 3 Surgical Procedures, Operative 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Neoadjuvant Therapy 3 Laparoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × atezolizumab × Clear all

NCT03363867 2023-08-07

BEACON

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡